Arterial plasma noradrenaline predicts left ventricular mass independently of blood pressure and body build in men who develop hypertension over 20 years-Reference-Cited by-同舟云学术

Arterial plasma noradrenaline predicts left ventricular mass independently of blood pressure and body build in men who develop hypertension over 20 years

Published:2006-05 Issue:5 Volume:24 Page:905-913
ISSN:0263-6352
Container-title:Journal of Hypertension
language:en
Short-container-title:

Author:

Strand Arne H,Gudmundsdottir Helga,Os Ingrid,Smith Gunnar,Westheim Arne S,Bjørnerheim Reidar,Kjeldsen Sverre E

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference42 articles.

1. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men;Casale;Ann Intern Med,1986

2. Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart Study;Levy;Ann Intern Med,1989

3. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study;Levy;N Engl J Med,1990

4. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death;Haider;J Am Coll Cardiol,1998

5. Cardioreparation and the concept of modulating cardiovascular structure and function;Weber;Blood Press,1993

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. (Myocardium Remodelling: From Adaptation Mechanisms to Heart Failure Development);Cor et Vasa;2024-03-05

2. Cardiac Mechanics: The Physiology, Mechanism, and Toxicology of the Heart׳s Function as a Pump;Reference Module in Biomedical Sciences;2024

3. The role of SGLT2i in attenuating residual cardiovascular risk through blood pressure-lowering: mechanistic insights and perspectives;Frontiers in Clinical Diabetes and Healthcare;2023-09-26

4. Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development;Reviews in Cardiovascular Medicine;2022-05-06

5. Sympathetic hyperactivity in patients with hypertension: pathogenesis and treatment. Part I;Cardiovascular Therapy and Prevention;2020-12-31